Berger Dietmar 4

What Happened
Dietmar Berger, Chief Medical Officer of Gilead Sciences (GILD), exercised/converted derivatives for 2,133 shares on March 10, 2026, and had 1,063 shares surrendered/withheld to cover tax obligations, yielding $157,919. On the same date he was granted awards totaling 39,890 derivative units (8,415 and 31,475 units as reported). The actions are primarily an option/derivative exercise plus receipt of company awards (not an open‑market purchase or sale for investment).

Key Details

• Transaction date: 2026-03-10; Form 4 filed: 2026-03-12 (filed timely within the typical two-business-day window).
• Exercise/conversion (code M): 2,133 derivative units converted to shares (acquired).
• Tax withholding/payment (code F): 1,063 shares surrendered at $148.56 per share, proceeds reported $157,919 (disposed to cover taxes/exercise costs).
• Additional derivative disposition: 2,133 derivative units are also listed as disposed in the filing (reflecting the conversion/settlement mechanics).
• Grants/awards (code A): 8,415 derivative units and 31,475 derivative units were reported as granted/awarded (total = 39,890 units). The filing shows a $0.00 strike for the 31,475 units as reported.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnotes: F1 = each RSU represents right to one share; F2 = RSUs vest over four years (25% at one year, then 6.25% quarterly); F3 = stock options vest over four years on the same schedule.

Context

• The filing indicates a standard exercise/settlement plus company awards and a share withholding to satisfy tax liabilities — a routine administrative disposition rather than an open‑market sale for investment reasons.
• The granted units appear to be compensation awards (RSUs and/or options subject to vesting); the filing’s footnotes show four‑year vesting schedules.
• For retail investors: awards and exercises by executives typically reflect compensation events and vesting schedules; the tax‑withholding disposition is common and not necessarily a signal of intent to sell remaining holdings.